...
首页> 外文期刊>International Journal of Reproduction, Contraception, Obstetrics and Gynecology >Role of camylofin and its combinations in obstetrics and gynaecological practice: a review of Indian evidence
【24h】

Role of camylofin and its combinations in obstetrics and gynaecological practice: a review of Indian evidence

机译:卡米洛芬及其组合在妇产科实践中的作用:印度证据综述

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Anti-spasmodic drugs like camylofin are used in obstetrics and gynaecological practice for broadly two conditions - spasmodic abdominal pain and management of prolonged labor. Camylofin has been in use in India for almost six decades. As a spasmolytic, camylofin has demonstrated good efficacy and tolerability, both in the management of abdominal spasmodic pain and in augmentation of labor. Literature evidences has suggested that camylofin has demonstrated a statistically significant superiority, such as higher spasmolytic potency compared to other anti-spasmodics like drotaverine, hyoscine and valethamate. In some studies, camylofin maintained the superior efficacy, despite being given as a single dose compared to repeat doses of comparator drugs. Also, in augmentation of labor, camylofin single dose demonstrated superior efficacy when the comparator arm was given a combination of two anti-spasmodic drugs i.e. hyoscine and valethamate in three doses at hourly intervals. Clinical studies in abdominal colic pain revealed significant superiority of the camylofin-paracetamol combination over dicylomine paracetamol combination, this despite the camylofin combination containing 300mg paracetamol as compared to the dicyclomine combination containing 500mg paracetamol. Similar results, highlighting better outcomes in abdominal colic of different types, was shown in studies comparing camylofin-diclofenac combination compared with hyoscine (in renal colic) and also camylofin-mefenamic acid combination compared with dicyclomine-mefenamic acid combination (in menstrual colic). All the above clinical study results resonate in the findings of a recent survey with gynaecologists across the country, which showed that camylofin is considered as the anti-spasmodic most suitable for female patients compared to drotaverine, dicyclomine and hyoscine. Given the availability of strong clinical trial data in Indian women patients, camylofin along with its combinations holds a strong place in the armamentarium of practicing obstetricians and gynaecologists and can be a preferred choice of therapy in treatment protocols of abdominal spasmodic pain and augmentation of labor.
机译:诸如卡米洛芬之类的抗痉挛药物在产科和妇科实践中广泛用于两种情况-痉挛性腹痛和长时间分娩。卡米洛芬在印度已经使用了近六十年。作为一种解痉剂,卡米洛芬在控制腹部痉挛性疼痛和增加分娩方面均显示出良好的疗效和耐受性。文献证据表明,卡米洛芬具有统计学上的显着优势,例如,与其他抗痉挛药如Drotaverine,Hyscine和valethamate相比,具有更高的解痉作用。在一些研究中,尽管与重复剂量的比较药物相比,单次给予卡米洛芬仍能保持优异的疗效。另外,在增加分娩时,当比较组接受每小时两种剂量的两种抗痉挛药物,即hy碱和戊酸的组合时,单剂卡米洛芬显示出更好的疗效。腹部绞痛的临床研究表明,卡米洛芬-扑热息痛联合用药比双环丙胺扑热息痛联用有明显优势,尽管卡米洛芬联合用药含有300mg对乙酰氨基酚,而双环胺联用含有500mg对乙酰氨基酚。在比较卡米洛芬-双氯芬酸联合与os嗪(在肾绞痛中)以及卡米洛芬-美芬那酸联合与二环胺-苯甲酸联合(月经绞痛)中进行比较的研究显示出相似的结果,突出了不同类型的腹绞痛的更好结局。以上所有临床研究结果均与全国妇科医生最近的一项调查结果相吻合,该调查表明与卡洛芬相比,卡维洛芬是最适合女性患者的抗痉挛药,与屈他维林,双环明和hy碱相比。鉴于印度女性患者可获得强大的临床试验数据,卡米洛芬及其组合在产科医生和妇科医生的药房中占有很重要的位置,在腹部痉挛性疼痛和增加分娩的治疗方案中可以作为首选的治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号